National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting, 90023 [2024-26479]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 220 / Thursday, November 14, 2024 / Notices
Date: December 3, 2024.
Time: 11:00 a.m.–12:00 p.m.
Agenda: The Novel and Exceptional
Technology and Research Advisory
Committee (NExTRAC) will receive an
update from the Working Group on Engaging
the Public as Partners in Clinical Research
and discuss the next steps regarding the
current charge to the committee, delivered in
August 2023.
Address: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Suite
630, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Meeting Access Link: Virtual Meeting Link
will be available at https://osp.od.nih.gov/
policies/novel-and-exceptional-technologyand-research-advisory-committeenextrac#tab4/.
Contact Person: Jessica Tucker, Ph.D.,
Office of Science Policy, National Institutes
of Health, 6705 Rockledge Drive, Suite 630,
Bethesda, MD 20892, 301–496–9838,
SciencePolicy@od.nih.gov.
Any interested person may file written
comments by forwarding the statement to the
Contact Person listed on this notice at least
two business days prior to the meeting date.
The statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person. Other
than name and contact information, please
do not include any personally identifiable
information or any information that you do
not wish to make public. Proprietary,
classified, confidential, or sensitive
information should not be included in your
comments. Please note that any comments
NIH receives may be posted unredacted to
the Office of Science Policy website.
Information is also available on the NIH
Office of Science Policy website: https://
osp.od.nih.gov/policies/novel-andexceptional-technology-and-researchadvisory-committee-nextrac#tab4, where an
agenda, link to the webcast meeting, and any
additional information for the meeting will
be posted when available. Materials for this
meeting will be posted prior to the meeting.
Please check this website for updates.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: November 7, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–26426 Filed 11–13–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
20:16 Nov 13, 2024
Jkt 265001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Arthritis and
Musculoskeletal and Skin Diseases
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: January 28, 2025.
Open: 9:30 a.m. to 3:00 p.m.
Agenda: Call to Order; NIAMS Director’s
Report and Discussion; Open Discussion.
Address: National Institutes of Health, 31
Center Street, Bethesda, MD 20892, (Virtual
Meeting).
Closed: 3:15 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Address: National Institutes of Health, 31
Center Street, Bethesda, MD 20892, Virtual
Meeting.
Contact Person: Darren D. Sledjeski, Ph.D.,
Director, Division of Extramural Activities
(DEA), National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd., Bethesda, MD 20892, (301)
451–7766, darren.sledjeski@nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
90023
In the interest of security, NIH has
procedures at https://www.nih.gov/
about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal
facility will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.niams.nih.gov/about/workinggroups/advisory-council, where an
agenda and any additional information
for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: November 8, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–26479 Filed 11–13–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government Owned Inventions
Available for Licensing or
Collaboration: Machine Learning
Model for the Prioritization of Cancer
Neoepitopes
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Cancer Institute
(NCI), an institute of the National
Institutes of Health (NIH), Department
of Health and Human Services (HHS), is
giving notice of licensing and
collaboration opportunities for the
inventions listed below, which are
owned by an agency of the U.S.
Government and are available for
license and collaboration in the U.S. to
achieve expeditious commercialization
of results of federally-funded research
and development.
FOR FURTHER INFORMATION CONTACT:
Inquiries related to a collaboration
opportunity should be directed to: Aida
Cremesti, Senior Technology Transfer
Manager, NCI, Technology Transfer
Center, Email: aida.cremesti@nih.gov or
Phone: 240–276–6641. Inquiries related
SUMMARY:
E:\FR\FM\14NON1.SGM
14NON1
]]>Agencies
[Federal Register Volume 89, Number 220 (Thursday, November 14, 2024)]
[Notices]
[Page 90023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26479]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Arthritis
and Musculoskeletal and Skin Diseases Advisory Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Arthritis and Musculoskeletal and
Skin Diseases Advisory Council.
Date: January 28, 2025.
Open: 9:30 a.m. to 3:00 p.m.
Agenda: Call to Order; NIAMS Director's Report and Discussion;
Open Discussion.
Address: National Institutes of Health, 31 Center Street,
Bethesda, MD 20892, (Virtual Meeting).
Closed: 3:15 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Address: National Institutes of Health, 31 Center Street,
Bethesda, MD 20892, Virtual Meeting.
Contact Person: Darren D. Sledjeski, Ph.D., Director, Division
of Extramural Activities (DEA), National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701 Democracy Blvd., Bethesda,
MD 20892, (301) 451-7766, [email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a meeting
on campus or at an off-campus federal facility will be asked to show
one form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: https://www.niams.nih.gov/about/working-groups/advisory-council,
where an agenda and any additional information for the meeting will be
posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: November 8, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-26479 Filed 11-13-24; 8:45 am]
BILLING CODE 4140-01-P
